Latest DEF 14A proxy statements

NASDAQ
Aptevo Therapeutics Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 21, 2026, to elect directors, ratify auditors, and approve an updated stock incentive plan.
NASDAQ
Vistagen Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for September 10, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.
NASDAQ
Interparfums, Inc. has filed its proxy statement for the September 15, 2026 annual meeting, detailing director elections, executive compensation, and a stock option plan extension.
NASDAQ
FibroBiologics is holding a special meeting on September 17, 2026, to seek stockholder approval for the issuance of up to 8,163,266 shares of common stock upon warrant exercise, a move necessary to comply with Nasdaq Listing Rule 5635(d).
NYSE
Methode Electronics, Inc. has issued its proxy statement detailing the upcoming 2026 Annual Meeting of Stockholders, scheduled for September 16, 2026, which will be a virtual meeting.
NASDAQ
Daily Journal Corporation is holding a special meeting on September 10, 2026, to vote on amending its Articles of Incorporation to eliminate cumulative voting rights in director elections.
NASDAQ
Ocugen is holding a special meeting on September 21, 2026, to seek shareholder approval to amend its charter to increase the number of authorized common stock shares by 250 million.
NASDAQ
Andretti Acquisition Corp. II is holding a special meeting on August 28, 2026, to seek shareholder approval for a one-year extension to consummate a business combination, moving the deadline from September 9, 2026, to September 9, 2027.
NYSE
Lamb Weston Holdings, Inc. is holding its 2026 Annual Meeting of Shareholders on September 16, 2026, to elect directors, approve executive compensation, and ratify auditor selection.
NASDAQ
Powerfleet, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on September 16, 2026, with key proposals including director elections and incentive plan amendments.
NASDAQ
Quantum Corporation announces its 2026 Annual Meeting of Shareholders, detailing proposals for director elections, amendments to its Long-Term Incentive Plan, executive compensation, and auditor ratification.
NASDAQ
Freedom Holding Corp. has issued its definitive proxy statement detailing the upcoming 2026 Annual Meeting of Stockholders, scheduled for September 16, 2026, to be held virtually.
NASDAQ
Alchemy Investments Acquisition Corp. is holding its annual general meeting on September 1, 2026, to vote on extending the deadline to complete its proposed business combination with Cartiga, LLC.
NASDAQ
Motorcar Parts of America announces its 2026 Annual Meeting of Shareholders, set for September 10, 2026, to elect directors, ratify auditors, and vote on executive compensation and incentive plans.
OID
Earth Science Tech, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, preferred stock retirement, reverse stock split consideration, and executive compensation.
NASDAQ
Roivant Sciences Ltd. has issued its proxy statement for the 2026 Annual General Meeting of Shareholders, detailing proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
NetApp, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for September 9, 2026, and provided a recap of its record-setting fiscal year 2026 performance.
NASDAQ
Polaryx Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for September 10, 2026, to elect directors and ratify auditor appointment.
NASDAQ
MIRA Pharmaceuticals, Inc. has issued a proxy statement detailing its upcoming virtual Annual Meeting of Shareholders on September 11, 2026, where key proposals including director elections and auditor ratification will be addressed.
NASDAQ
Telomir Pharmaceuticals, Inc. has issued a proxy statement detailing its upcoming Annual Meeting of Shareholders, scheduled for September 11, 2026, to elect directors, ratify auditor appointment, and address other business.
NASDAQ
Sonoma Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Stockholders Meeting, scheduled for September 16, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.
NYSE
Lionsgate Studios Corp. has announced its 2026 Annual General and Special Meeting of Shareholders, scheduled for September 15, 2026, detailing proposals for director elections, auditor re-appointment, and executive compensation.
NASDAQ
Kestra Medical Technologies, Ltd. is holding its 2026 Annual General Meeting of Shareholders virtually on September 9, 2026, to elect directors and ratify auditor appointment.
NASDAQ
RF Industries, Ltd. announces its 2026 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification.
NASDAQ
Friedman Industries, Inc. has announced its Annual Meeting of Shareholders will be held on September 22, 2026, to elect directors, vote on executive compensation, ratify auditors, and consider bylaw amendments.
NASDAQ
Daktronics, Inc. has issued its proxy statement for the September 16, 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation approval, and auditor ratification.
NASDAQ
Jerash Holdings (US), Inc. announces its 2026 Annual Meeting of Stockholders, detailing director nominations, executive compensation advisory vote, and highlighting record sales and improved margins for fiscal 2026.
NASDAQ
Gen Digital Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on September 9, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NASDAQ
LiveOne, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for September 17, 2026, to elect directors, approve an equity incentive plan, and ratify auditor appointment.
NASDAQ
Sow Good Inc. is holding a special meeting on August 10, 2026, to vote on a proposed amendment to its Certificate of Incorporation that would allow stockholders to act by written consent.